Mirati - oncology?

[anonymous]

The board hired him after the insane track record. They need to beheld accountable for the train wreck

How does the board feel about having a CEO who’s destroyed 3/4 of shareholder value on his watch?

 

[anonymous]

The board hired him after the insane track record. They need to beheld accountable for the train wreck

That’s funny!

Accountability is for the little people, not those at the top.

 

[anonymous]

Meek is way fat.

 

[anonymous]

The board hired him after the insane track record. They need to beheld accountable for the train wreck

One word - Fergene

 

[anonymous]

Has everyone figured out that Meek is an untrustworthy POS?

 

[anonymous]

Has everyone figured out that Meek is an untrustworthy POS?

He is in good company. Like pigs in shit until they get their mega parachute payments. Stinks.

 

[anonymous]

Meek is a prat.

 

[anonymous]

The stock is still defying gravity. It’s not worth a dime over 25-30 bucks a share. That might even be way too much.

 

[anonymous]

Meek’s handiwork:

European Commission rejects Ipsen’s ultra-rare disease drug after two negative opinions from EMA – Endpoints News

European Commission rejects Ipsen’s ultra-rare disease drug after two negative opinions from EMA – Endpoints News

 

[anonymous]

Meek’s handiwork:

European Commission rejects Ipsen’s ultra-rare disease drug after two negative opinions from EMA – Endpoints News

European Commission rejects Ipsen’s ultra-rare disease drug after two negative opinions from EMA – Endpoints News

And now does the same for KRAZATI. Cluster fuck!

 

[anonymous]

More handiwork by Meek
How low can it go

layoffs are coming

Meek’s handiwork:

European Commission rejects Ipsen’s ultra-rare disease drug after two negative opinions from EMA – Endpoints News

European Commission rejects Ipsen’s ultra-rare disease drug after two negative opinions from EMA – Endpoints News

 

[anonymous]

Meek’s handiwork:

European Commission rejects Ipsen’s ultra-rare disease drug after two negative opinions from EMA – Endpoints News

European Commission rejects Ipsen’s ultra-rare disease drug after two negative opinions from EMA – Endpoints News

Nothing but bad news with this management team. BOD needs to clean house starting with CEO and CFO. Bring Chuck back!

 

[anonymous]

Krapati…


Mirati’s KRAS-blocking cancer drug hits setback in Europe | BioPharma Dive

https://www.biopharmadive.com/news/mirati-ema-krazati-recommend-rejection-cancer/688626/

A key committee for the European Medicines Agency recommended against approval of the targeted therapy, citing a lack of comprehensive data about how well it works.

 

[anonymous]

The drug is no doubt better than lumakras. The c suite just mismanaged the crap out of it and the company. You can’t make up half the shit that happened.

And CEO CCO CFO CSO HR all need to be held accountable

 

[anonymous]

My resume is out, doctors do not want to use this.

 

[anonymous]

More handiwork by Meek
How low can it go

layoffs are coming

Are we going to talk about how Fergene imploded on his watch too?

 

[anonymous]

I know most of their Medical Affairs staff. They hired, well, people no other company wanted. They got what they hired…dregs.

 

[anonymous]

I know most of their Medical Affairs staff. They hired, well, people no other company wanted. They got what they hired…dregs.

Meek’s executive hires have been horrible throughout his career. Either he can’t recognize or is intimidated by top talent.

 

[anonymous]

How dropped that big stanky in the bowl ? Is it time to flush Mirati down ?

 

[anonymous]

The stock is still defying gravity. It’s not worth a dime over 25-30 bucks a share. That might even be way too much.

as I was saying